Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective
- 6 March 2023
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 23 (4) , 439-447
Abstract
Cervical cancer is one of the most common cancers in women, the cause of which is mostly human papilloma virus (HPV). The aim of this study was to determine the economic burden of cervical cancer a...Keywords
This publication has 36 references indexed in Scilit:
- Improving women’s health in low-income and middle-income countries. Part INuclear Medicine Communications, 2017
- The impact on women’s health and the cervical cancer screening budget of primary HPV screening with dual-stain cytology triage in BelgiumEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2017
- The Effect of Education on the Early Diagnosis of Breast and Cervix Cancer on the Women’s Attitudes and Behaviors Regarding Participating in Screening ProgramsJournal of Cancer Education, 2017
- How to Estimate Productivity Costs in Economic EvaluationsPharmacoEconomics, 2014
- Cobertura y costes del cribado oportunista de detección precoz del cáncer de cuello uterino en CantabriaGaceta Sanitaria, 2014
- The cost-effectiveness of male HPV vaccination in the United StatesVaccine, 2011
- Economic burden of HPV-related cancers in FranceVaccine, 2011
- Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in BelgiumJournal of Medical Economics, 2008
- Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UKCurrent Medical Research and Opinion, 2006
- Care and costs for advanced cervical cancerEuropean Journal of Cancer, 1992